17Feb 2023

MEDICAL MANAGEMENT OF OCULAR SARCOIDOSIS

  • Junior Resident, Department Of Ophthalmology, Government Medical College and Hospital, Aurangabad.
  • Head of Department, Department of Ophthalmology, Government Medical College and Hospital, Aurangabad.
  • Professor, Department of Ophthalmology, Government Medical College and Hospital, Aurangabad.
Crossref Cited-by Linking logo
  • Abstract
  • Keywords
  • Cite This Article as
  • Corresponding Author

Sarcoidosis is one of the leading causes of inflammatory eye disease. Ocular sarcoidosis can involve any part of the eye and its adnexal tissues, and may cause uveitis, episcleritis/scleritis, eyelid abnormalities, conjunctival granuloma, optic neuropathy, lacrimal gland enlargement and orbital inflammation. Glaucoma and cataract can be complications from inflammation itself or adverse effects from therapy. Ophthalmic manifestations can be isolated, or associated with other organ involvement. Patients with ocular sarcoidosis can present with a wide range of clinical presentations and severity. Multi-disciplinary approaches are required to achieve the best treatment outcomes for both ocular and systemic manifestations. 


[Ruchika Y. Jumle, Kashinath G. Choudhary and Shubha C. Ghonsikar (2023); MEDICAL MANAGEMENT OF OCULAR SARCOIDOSIS Int. J. of Adv. Res. 11 (Feb). 1079-1084] (ISSN 2320-5407). www.journalijar.com


Ruchika Y. Jumle
Dr
India

DOI:


Article DOI: 10.21474/IJAR01/16346      
DOI URL: http://dx.doi.org/10.21474/IJAR01/16346